Sullivan Christopher Ryan bought AVTX
August 18, 2026 · Form 4 insider transaction
Sullivan Christopher Ryan bought 31,031 shares of Avalo Therapeutics, Inc. at $9.88 per share, a transaction worth $306.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
31,031
Price
$9.88
Total value
$306.6K
InsiderSullivan Christopher Ryan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 18, 2026
Filing dateAugust 19, 2026
Shares owned after70,931
OwnershipDirect
10b5-1 planNo
AmendedNo